Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Nov 7, 2017

Sanofi and Regeneron to Present New Analyses from the Praluent® (alirocumab) Injection ODYSSEY Clinical Trial Program at the AHA Scientific Sessions 2017
Nov 2, 2017

Sanofi: Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
- Photos 5
Oct 31, 2017

Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function in a Phase 3 Study of People with Severe Steroid-Dependent Asthma

First study with a biologic to show benefit in severe steroid-dependent asthma population that enrolled patients regardless of blood eosinophil levels or any other Type 2 biomarkers at baseline
Oct 19, 2017

Sanofi Pasteur and VaxServe’s Lackawanna County Community Fundraiser Marks 10 Years and Surpasses $1 Million Raised for Local Children and Families
Oct 16, 2017

Sanofi and Regeneron Announce Positive Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis

- Late-breaking oral abstract presented at the World Congress of Gastroenterology -

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.